Login / Signup

Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity.

Natasha D SheybaniAlexandra R WitterEric A ThimHideo YagitaTimothy N J BullockRichard J Price
Published in: Journal for immunotherapy of cancer (2021)
NCT03237572 and NCT04116320.
Keyphrases
  • locally advanced
  • squamous cell carcinoma
  • light emitting
  • breast cancer risk